Earningsreport

Q2/2018 6/30/2018 EPS -0.840 ZacksConsensus N/A ActVsEst N/A - N/A

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations